Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

CEPT inhibitors designed at Merck & Co.

Feb. 20, 2015

Metabolic Solutions Development divulges PPAR-sparing compounds

Feb. 20, 2015

Stealth BioTherapeutics initiates clinical study of Bendavia for mitochondrial myopathy

Feb. 19, 2015

CER-001 shows safety and efficacy in FHA patients

Feb. 19, 2015

Sprout Pharmaceuticals resubmits NDA for flibanserin in HSDD

Feb. 18, 2015

Hanmi initiates phase I trial of weekly-dosing formulation of basal insulin

Feb. 17, 2015

JDRF supports Janssen's disease interception approach to prevent onset of type 1 diabetes

Feb. 16, 2015

Amyloid light-chain amyloidosis treatments receive FDA orphan drug status

Feb. 13, 2015

Bayer Schering Pharma discloses GnRH receptor antagonists

Feb. 13, 2015

Novo Nordisk funds diabetes research at Karolinska Institutet

Feb. 12, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...